Q4 2025 Management View Interim CEO Rick Carnifax stated that "Q4 and 2025 overall were defined by decisive action, operational discipline and measurable progress toward putting UEI back on the path ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Krishna Kutty In Star ...

Q4 2025 Management View CEO Lawrence Fey announced a refreshed leadership team, with Austin Arnett appointed as General Counsel in December and Joe Thomas joining as Chief Financial Officer in January ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--With U.S. healthcare costs expected to grow between six and eight percent again this year, plan sponsors chose “cost reduction” as their top priority when ...

Chairman & CEO G. Timothy Laney reported "earnings of $0.88 during the second quarter with a 14.2% return on tangible equity and a 1.5% return on assets." Laney highlighted a "strong net interest ...

Since the Deloitte Center for Health Solutions began surveying healthcare finance leaders in 2020, cost reduction has consistently been a top three organizational priority or concern. But in 2024, ...

Management indicated continued focus on reducing expenses, limiting capital spending, and driving operational efficiencies for the remainder of 2025. Lolmaugh stated, "We intend to place further ...

Facing a shifting energy demand landscape, many energy and chemicals (E&C) companies have cost-reduction on their minds. Geopolitical tensions, which often drive-up oil and natural gas prices, are ...

In the latest attempt to solve a looming budget shortfall, the Kane County Board has OK’d a recommendation that county offices and departments reduce their expenses by roughly 8% from last year’s ...

ADDISON, Texas--(BUSINESS WIRE)--Expense Reduction Analysts (ERA), a global leader in cost management consulting, is continuing to provide cost-saving solutions to companies and non-profits across ...

Leiden, the Netherlands, October 6, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the implementation of an organizational restructuring to ...

VALLEY FORGE, PA (February 3, 2025)—Vanguard today announced historic expense ratio reductions to one hundred sixty-eight mutual fund and exchange-traded share classes across eighty-seven funds. The ...